Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in TET2, DNMT3 and CUX1 - azacitidine induces only lymphoma remission.
Magnus TobiassonTatjana PandzicLucia CavelierBirgitta SanderBjörn Engelbrekt WahlinPublished in: Leukemia & lymphoma (2019)